Skip to main content
OpenTrials
Completed

NCT Number: NCT05986825

Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)

Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Patient with Verneuil disease
  • Beneficiary of or affiliated to a social security insurance
  • Participation agreement

Exclusion criteria

  • Patients physically or mentally unable to complete questionnaires.
  • Refusal to participate
  • Patient under legal protection (guardianship, curatorship) or deprived of liberty

Treatment and study plan

Verneuil questionnaire Validation

Other

Request patient to Complete the questionnaire for validation of the French version

Primary outcomes

  1. Validation of the questionnaire

    Time frame: During the visit and 1 week later

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: QUALIVER

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 14, 2023
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.